Scientech Research LLC’s Vir Biotechnology VIR Stock Holding History

Scientech Research LLC’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,021	Closed	-$72.5K	–	751
2025 Q4	$72.5K	Buy	+12,021	New	+$71.6K	0.05%	429

Other funds holding VIR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

GSK plc London $602M AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Scientech Research LLC's VIR Position: Q1 2026 in Review

Scientech Research LLC sold out of Vir Biotechnology (VIR) in Q1 2026, closing a stake of 12,021 shares — an estimated $72.5K sold.

Scientech Research LLC first reported a position in VIR in Q4 2025 and held it in 1 quarter. The position peaked at $72.5K in Q4 2025. 252 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

Scientech Research LLC reported no remaining Vir Biotechnology position as of Q1 2026 after selling out during the quarter.
Scientech Research LLC sold 12,021 Vir Biotechnology shares in Q1 2026, an estimated $72.5K.
Scientech Research LLC first reported a position in Vir Biotechnology in Q4 2025 and held it in 1 quarter.
Scientech Research LLC's Vir Biotechnology position peaked at $72.5K in Q4 2025.
252 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Scientech Research LLC's 13F filing for Q1 2026, filed 15 May 2026.